Loading...

ACET ADICET BIO INC Management Changes 8-K Filing

DCT

CT

ADICET BIO INC

(ACET)

2025 8-K

Show Summary

Summary

Financial Statements

New Collaboration

Clinical Trial Update

Clinical Trial Update

Loan Termination

Clinical Trials Update

Loan Agreement Amendment

Financial Results

Clinical Trial Update

Clinical Data Release

Strategic Focus Shift

Financial Results

FDA Fast Track Designation ...

FDA Clearance of IND Applic...

Amendment to Stock Option a...

FDA Fast Track Designation ...

Financial Results Announcement

Presentation at ASGCT

Open Market Sales Agreement

Financial Results Announcement

Underwriting Agreement and ...

Corporate Presentation

Corporate Update and Strate...

Resignation of Director

Financial Results Announcement

Financial Results Announcement

Phase 1 Trial Data

Loan Agreement Amendment

Annual Meeting Results

Financial Results Announcement

Financial Results Announcement

No Business Relationship wi...

External Links:

On June 11, 2025, Adicet Bio, Inc. held its Annual Meeting where stockholders elected two directors, approved executive compensation, and ratified KPMG as their auditors for 2025. Votes included 32.4M for Chen Schor and 32.9M for Katie Peng; executive compensation received 31.2M votes for; and KPMG's appointment was ratified with 58.5M votes.

AI Assistant

ADICET BIO INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.